Fulgent Genetics Other Long-Term Assets 2015-2025 | FLGT
Fulgent Genetics other long-term assets from 2015 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Fulgent Genetics Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $33 |
| 2023 | $55 |
| 2022 | $57 |
| 2021 | $33 |
| 2020 | $4 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| Fulgent Genetics Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $33 |
| 2024-12-31 | $33 |
| 2024-09-30 | $39 |
| 2024-06-30 | $53 |
| 2024-03-31 | $53 |
| 2023-12-31 | $55 |
| 2023-09-30 | $53 |
| 2023-06-30 | $62 |
| 2023-03-31 | $58 |
| 2022-12-31 | $57 |
| 2022-09-30 | $72 |
| 2022-06-30 | $74 |
| 2022-03-31 | $52 |
| 2021-12-31 | $33 |
| 2021-09-30 | $29 |
| 2021-06-30 | $9 |
| 2021-03-31 | |
| 2020-12-31 | $4 |
| 2020-09-30 | $1 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2014-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.588B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.804B | 58.27 |
| Tempus AI (TEM) | United States | $11.365B | 0.00 |
| Doximity (DOCS) | United States | $10.890B | 50.42 |
| Hims & Hers Health (HIMS) | United States | $9.396B | 97.63 |
| IRhythm Technologies (IRTC) | United States | $4.819B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.834B | 59.90 |
| Hinge Health (HNGE) | United States | $3.409B | 0.00 |
| Privia Health (PRVA) | United States | $2.635B | 180.08 |
| Enovis (ENOV) | United States | $1.711B | 9.54 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Schrodinger (SDGR) | United States | $1.493B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.440B | 0.00 |
| Azenta (AZTA) | United States | $1.334B | 61.98 |
| Omnicell (OMCL) | United States | $1.329B | 23.45 |
| 10x Genomics (TXG) | United States | $1.329B | 0.00 |
| Evolent Health (EVH) | United States | $1.233B | 105.00 |
| Claritev (CTEV) | United States | $0.682B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.507B | 0.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Talkspace (TALK) | United States | $0.462B | 138.00 |
| TruBridge (TBRG) | United States | $0.337B | 748.33 |
| Outset Medical (OM) | United States | $0.308B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.158B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.133B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 4.02 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| Pulmonx (LUNG) | United States | $0.103B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |